Medley
VC Fund
Tokyo, Japan
Medley is a VC fund in Tokyo focused on Apps and Health Care. MEDLEY, the online encyclopedia disease that doctors make along with the people of cooperation doctor hundreds of people, we have put together in an easy-to-understand gently variety of information about the disease.Connect the people of doctors and medical institutions that provide people and their families and medical services to receivemedical care, we aim to become as to realize the "convincing medical" information infrastructure must-have in society .
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Medley invests in
Stages Medley invests in
Countries Medley invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 10 contacts → | |||
Round size
- Seed
- $383k–$383k
Investment Focus
Industry
- Apps 2 (50%)
- Health Care 2 (50%)
- Health Diagnostics 2 (50%)
- Medical 1 (25%)
- Software 1 (25%)
Stage
- Seed 1 (25%)
- Series A 1 (25%)
- Venture - Series Unknown 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Takiguchi Kohei
President, CEO, and Founder
|
President, CEO, and Founder | Total investments: 2 | Find email | |
|
Goichiro Toyoda
Representative Director Doctor
|
Representative Director Doctor | Total investments: 1 | Find email | |
|
Kamachi Masahide
Outside Corporate Auditors
|
Outside Corporate Auditors | Total investments: 0 | Find email | |
|
Kato Kyosuke
Executive officer
|
Executive officer | Total investments: 2 | Find email | |
|
Keiichi Kato
Outside Corporate Auditor
|
Outside Corporate Auditor | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Equitas Medical provides management support for clinics, including operational improvement, strategic planning, recruitment, digital transformation, and back-office administration. It supports business succession for clinic owners by providing transition options intended to maintain patient and staff continuity. The company also promotes healthcaredigital transformation through AI, cloud services, remote-care tools, hospital real-world data use, and medical department digitalization. Its services are intended for healthcare professionals, clinic owners, and healthcare organizations. | $383.4K / Seed / Aug 03, 2026 | ||
| Hedgehog Medtech is a medical firm focused on digital therapeutics (DTx). DTx is a pharmaceutically approved programmable medical device that assists patients' medical operations via smartphone apps. | Venture - Series Unknown / Dec 19, 2025 | ||
| HITOTSU is a software development company that provides medical device management systems for all hospitals and clinics. | $746.3K / Series A / Jul 11, 2025 | ||
| See all 4 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Medley invest in?
Medley invests primarily in Apps, Health Care and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 4 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Medley's check size?
Medley typically joins rounds of $383k–$383k at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Medley participates in.
How do I contact Medley?
Public channels for Medley include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Medley?
The team at Medley includes Takiguchi Kohei (President, CEO, and Founder), Goichiro Toyoda (Representative Director Doctor) and Kamachi Masahide (Outside Corporate Auditors), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!